LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Kodu・Aktsiate loetelu・Pulse Biosciences Inc

Pulse Biosciences Inc

Suletud

SektorTervishoid

18.68 0.16

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.57

Max

18.8

Põhinäitajad
By Trading Economics
Sissetulek	2M -17M
Müük	178K 264K
Aktsiakasum	-0.29
Kasumimarginaal	-6,603.409
Töötajad	116
EBITDA	-2M -21M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+60.17% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	7. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-179M 958M
Eelmine avamishind	18.52
Eelmine sulgemishind	18.68

Uudiste sentiment

By Acuity

56%

44%

270 / 352 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

16.59 / 17.17 Toetus ja vastupanu

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. veebr 2026, 23:53 UTC

Kuumad aktsiad

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27. veebr 2026, 22:23 UTC

Omandamised, ülevõtmised, äriostud

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

28. veebr 2026, 21:36 UTC

Tulu

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28. veebr 2026, 15:20 UTC

Tulu

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- 2nd Update

28. veebr 2026, 14:43 UTC

Tulu

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28. veebr 2026, 14:40 UTC

Uudisväärsed sündmused

What Defense Stocks Stand to Gain -- and Lose -- From the U.S. Attacks on Iran -- Barrons.com

28. veebr 2026, 14:38 UTC

Tulu

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- Update

28. veebr 2026, 13:51 UTC

Uudisväärsed sündmused

What Defense Stocks Stand to Gain--and Lose--From the US Attacks on Iran -- Barrons.com

28. veebr 2026, 13:47 UTC

Tulu

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28. veebr 2026, 13:44 UTC

Tulu

Berkshire Hathaway Earnings Slip on Decline in Insurance Results -- WSJ

28. veebr 2026, 13:14 UTC

Tulu

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28. veebr 2026, 12:41 UTC

Uudisväärsed sündmused

Iran's Rulers Face an All-Out Battle for Survival -- Barrons.com

28. veebr 2026, 10:30 UTC

Omandamised, ülevõtmised, äriostud

All The Ways Netflix Actually Won Even Though It Lost Warner -- Heard on the Street -- WSJ

28. veebr 2026, 02:32 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Calpers Buys Into Hot Chip And Quantum Stocks -- Barrons.com

28. veebr 2026, 02:00 UTC

Omandamised, ülevõtmised, äriostud

Six Months, 9 Offers and $81 Billion. How Hollywood's Nasty Takeover Was Won. -- WSJ

28. veebr 2026, 02:00 UTC

Omandamised, ülevõtmised, äriostud

Six Months, 9 Offers and $81 Billion. How -2-

28. veebr 2026, 00:01 UTC

Omandamised, ülevõtmised, äriostud

Paramount Issuing $47 Billion of Equity at Big Premium to Stock Price for Warner Bros. Deal -- Barrons.com

27. veebr 2026, 23:46 UTC

Omandamised, ülevõtmised, äriostud

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27. veebr 2026, 23:33 UTC

Omandamised, ülevõtmised, äriostud

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27. veebr 2026, 21:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Tech, Media & Telecom Roundup: Market Talk

27. veebr 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27. veebr 2026, 21:30 UTC

Tulu

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27. veebr 2026, 21:30 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27. veebr 2026, 21:20 UTC

Omandamised, ülevõtmised, äriostud

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27. veebr 2026, 21:17 UTC

Tulu

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27. veebr 2026, 21:10 UTC

Omandamised, ülevõtmised, äriostud

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27. veebr 2026, 21:09 UTC

Omandamised, ülevõtmised, äriostud

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27. veebr 2026, 21:00 UTC

Tulu

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27. veebr 2026, 20:31 UTC

Omandamised, ülevõtmised, äriostud

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27. veebr 2026, 20:24 UTC

Market Talk

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

60.17% tõus

12 kuu keskmine prognoos

Keskmine 30 USD 60.17%

Kõrge 30 USD

Madal 30 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Pulse Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

16.59 / 17.17Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

270 / 352 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.